Clinical Trial Update: Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tributyrin for mild Alzheimer disease to assess the effects of butyrate via the gut-brain axis; study status is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Tributyrin (tributyrin)

Snippet

Sponsor: Universidad de Almeria | Conditions: Alzheimer Disease (AD) | Phase 3 | Status: NOT_YET_RECRUITING